Anthropic Inc. completes IPO listing on a US exchange or is first traded on Nasdaq by October 31, 2026 (confirmed by SEC EDGAR or Reuters by October 31, 2026)
Miss
✦ AI-generated prediction
Published on 17. September 2026
·
Predicted for 31. October 2026
·
Based on: Speculative
Anthropic Inc. confidentially filed its S-1 prospectus with the SEC on June 1, 2026. According to multiple financial media outlets and the StartupHub investor briefing, the timeline targets a Nasdaq listing in October 2026—median predicted listing date October 26, 2026. Goldman Sachs, JPMorgan, and Morgan Stanley are underwriting the offering. The targeted valuation is approximately $1.82–2.0 trillion; annualized revenue is reportedly around $65 billion. The 2026 IPO year is the strongest since 2021 with 331 new filings and 280 completed listings through Q3. Risk factors: regulatory delays from SEC review after confidential filing, market volatility following the dual rate shock, geopolitical uncertainty.
Data basis for this prediction
- Anthropic vertrauliche S-1-Einreichung bei der SEC: 1. Juni 2026 (Yahoo Finance, StartupHub AI News)
- Medianer vorhergesagter Listing-Termin: 26. Oktober 2026; Underwriter: Goldman Sachs, JPMorgan, Morgan Stanley (StartupHub, Juli 2026)
- Angestrebte Bewertung: ~1,82–2,0 Billionen USD; annualisierter Umsatz ~65 Mrd. USD (MarketWise, September 2026)
- 2026 IPO-Markt: 331 Neuemissionen, 280 abgeschlossen bis Q3 – Stärkstes Jahr seit 2021 (Seeking Alpha, September 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Miss
Anthropic reichte seinen S-1-Prospekt am 26. Oktober 2026 öffentlich bei der SEC ein und beantragte die Notierung an der Nasdaq unter dem Ticker 'ANT' – aber die tatsächliche Erstnotiz (erster Handelstag) fand bis zum 31. Oktober 2026 nicht statt. Laut Bloomberg (02.11.2026) und CNBC visiert Anthropic ein Börsendebüt in der Woche ab dem 16. November 2026 an, möglicherweise noch vor Thanksgiving (26. November). Die Vorhersage verlangte ausdrücklich eine vollzogene Börsenzulassung oder Erstnotiz bis 31.10.2026 – die S-1-Einreichung ist lediglich ein Schritt im Prozess, kein Abschluss des IPO. Quellen: SEC EDGAR (anthropicpbc-sx1.htm, 26.10.2026), Bloomberg 02.11.2026, CNBC 26.10.2026.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.
💻 Technology
✦ AI
ARM Holdings reports Q2 FY2027 (July–September 2026) on November 4 after market close. EPS consensus: $0.47; revenue consensus ~$1.38B (Theta Research, Oct 29). ARM is the dominant CPU IP licensor for AI servers (Neoverse), smartphones (Apple A-series, Qualcomm), and edge devices — all three segments scaling strongly in 2026. ARM has beaten EPS consensus in each of the last four quarters, driven by AI infrastructure capex. No direct Polymarket contract; analogue: S&P 500 Q3 2026 beat rate ~71%. Key risks: export control escalation (UK/US vs. China), hyperscaler capex delays, or HBM4 demand plateau.